Advertisement

World Journal of Surgery

, Volume 37, Issue 4, pp 878–882 | Cite as

A Nodal Positivity Constant: New Perspectives in Lymph Node Evaluation and Colorectal Cancer

  • Niamh M. Hogan
  • Desmond C. Winter
Article

Abstract

Purpose

To date, associations between the number of lymph nodes evaluated, staging, and survival have been examined in the context of large population-based studies conducted by a small number of investigators. Therefore, although high-quality data are available, perspective is lacking.

Methods

Studies for this paper were identified by searches of Medline, Scopus, PubMed, and manual searching of references from articles, using the search terms ‘‘colorectal cancer’’, ‘‘nodal status’’ and ‘‘lymph node’’.

Results

It is clear that survival benefit increases with the increasing number of lymph nodes harvested. Despite this observation, there has been no significant increase in the proportion of node-positive cancers over the past two decades.

Conclusion

The nodal positivity rate for colorectal cancer consistently approximates 40 % across a wide range of studies internationally, a phenomenon that has not previously been recognized in the literature. We review the evidence and introduce the concept of a nodal positivity constant.

Keywords

Colorectal Cancer Nodal Positivity Lymph Node Ratio Complete Mesocolic Excision Nodal Positivity Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Conflict of interest

None.

References

  1. 1.
    Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474PubMedCrossRefGoogle Scholar
  2. 2.
    Swanson RS, Compton CC, Stewart AK et al (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65–71PubMedCrossRefGoogle Scholar
  3. 3.
    Le Voyer TE, Sigurdson ER, Hanlon AL et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919PubMedCrossRefGoogle Scholar
  4. 4.
    Chang GJ, Rodriguez-Bigas MA, Skibber JM et al (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433–441PubMedCrossRefGoogle Scholar
  5. 5.
    Baxter NN, Ricciardi R, Simunovic M et al (2010) An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum 53:65–70PubMedCrossRefGoogle Scholar
  6. 6.
    Baxter NN (2009) Is lymph node count an ideal quality indicator for cancer care? J Surg Oncol 99:265–268PubMedCrossRefGoogle Scholar
  7. 7.
    Ricciardi R, Baxter NN (2007) Association versus causation versus quality improvement: setting benchmarks for lymph node evaluation in colon cancer. J Natl Cancer Inst 99:414–415PubMedCrossRefGoogle Scholar
  8. 8.
    Ricciardi R, Madoff RD, Rothenberger DA et al (2006) Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol 4:1522–1527PubMedCrossRefGoogle Scholar
  9. 9.
    Baxter NN, Morris AM, Rothenberger DA et al (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys 61:426–431PubMedCrossRefGoogle Scholar
  10. 10.
    Baxter NN, Virnig DJ, Rothenberger DA et al (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225PubMedCrossRefGoogle Scholar
  11. 11.
    Parsons HM, Tuttle TM, Kuntz KM et al (2011) Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA 306:1089–1097PubMedCrossRefGoogle Scholar
  12. 12.
    Center MM, Jemal A, Smith RA et al (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378PubMedCrossRefGoogle Scholar
  13. 13.
    Hohenberger W, Weber K, Matzel K et al (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Colorectal Dis 11:354–364 Discussion 364–355PubMedCrossRefGoogle Scholar
  14. 14.
    Silverstein MJ, Skinner KA, Lomis TJ (2001) Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 25:767–772. doi: 10.1007/s00268-001-0003-x PubMedCrossRefGoogle Scholar
  15. 15.
    Porter PL, El-Bastawissi AY, Mandelson MT et al (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91:2020–2028PubMedCrossRefGoogle Scholar
  16. 16.
    Hakama M, Holli K, Isola J et al (1995) Aggressiveness of screen-detected breast cancers. Lancet 345:221–224PubMedCrossRefGoogle Scholar
  17. 17.
    Prandi M, Lionetto R, Bini A et al (2002) Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg 235:458–463PubMedCrossRefGoogle Scholar
  18. 18.
    Anonymous (1999) Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer: International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) investigators. J Clin Oncol 17:1356–1363Google Scholar
  19. 19.
    Gill S, Loprinzi CL, Sargent DJ et al (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22:1797–1806PubMedCrossRefGoogle Scholar
  20. 20.
    Storli K, Sondenaa K, Furnes B et al (2011) Improved lymph node harvest from resected colon cancer specimens did not cause upstaging from TNM stage II to III. World J Surg 35:2796–2803. doi: 10.1007/s00268-011-1248-7 PubMedCrossRefGoogle Scholar
  21. 21.
    Johnson PM, Porter GA, Ricciardi R et al (2006) Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 24:3570–3575PubMedCrossRefGoogle Scholar
  22. 22.
    Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179–189PubMedCrossRefGoogle Scholar
  23. 23.
    Poller DN (2000) Method of specimen fixation and pathological dissection of colorectal cancer influences retrieval of lymph nodes and tumour nodal stage. Eur J Surg Oncol 26:758–762PubMedCrossRefGoogle Scholar
  24. 24.
    Wong SL (2011) Lymph node evaluation in colon cancer assessing the link between quality indicators and quality. JAMA 306:1139–1141PubMedCrossRefGoogle Scholar
  25. 25.
    Sobin LH, Compton CC (2010) TNM seventh edition: what’s new, what’s changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 116:5336–5339PubMedCrossRefGoogle Scholar
  26. 26.
    Puppa G, Sonzogni A, Colombari R et al (2012) TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch Pathol Lab Med 134:837–852Google Scholar
  27. 27.
    Ueno H, Mochizuki H, Hashiguchi Y et al (2001) Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg 234:190–197PubMedCrossRefGoogle Scholar
  28. 28.
    Kim JC, Lee KH, Yu CS et al (2004) The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer. Eur J Surg Oncol 30:271–279PubMedCrossRefGoogle Scholar
  29. 29.
    Newland RC, Dent OF, Lyttle MN et al (1994) Pathologic determinants of survival associated with colorectal cancer with lymph node metastases: a multivariate analysis of 579 patients. Cancer 73:2076–2082PubMedCrossRefGoogle Scholar
  30. 30.
    Huh JW, Kim YJ, Kim HR (2012) Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer. Ann Surg 255:70–78PubMedCrossRefGoogle Scholar
  31. 31.
    Soreide K (2011) Lymph node evaluation for colon cancer. JAMA 306:2669PubMedCrossRefGoogle Scholar
  32. 32.
    Soreide K, Nedrebo BS, Soreide JA et al (2009) Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location. World J Surg 33:2695–2703. doi: 10.1007/s00268-009-0255-4 PubMedCrossRefGoogle Scholar
  33. 33.
    Belt EJ, Te Velde EA, Krijgsman O et al (2011) High lymph node yield is related to microsatellite instability in colon cancer. Ann Surg Oncol 19:1222–1230PubMedCrossRefGoogle Scholar
  34. 34.
    Menon AG, Fleuren GJ, Alphenaar EA et al (2003) A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer. Cancer Immunol Immunother 52:121–126PubMedGoogle Scholar
  35. 35.
    Menon AG, Janssen-van Rhijn CM, Morreau H et al (2004) Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest 84:493–501PubMedCrossRefGoogle Scholar
  36. 36.
    Rushfeldt C, Sveinbjornsson B, Seljelid R et al (1999) Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense. J Surg Res 82:209–215PubMedCrossRefGoogle Scholar
  37. 37.
    Houston AM, Michael-Robinson JM, Walsh MD et al (2008) The “Fas counterattack” is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability. Hum Pathol 39:243–250PubMedCrossRefGoogle Scholar
  38. 38.
    Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874PubMedCrossRefGoogle Scholar
  39. 39.
    Loboda A, Nebozhyn MV, Watters JW et al (2011) EMT is the dominant program in human colon cancer. BMC Med Genomics 4:9PubMedCrossRefGoogle Scholar
  40. 40.
    Stricker T, Catenacci DV, Seiwert TY (2011) Molecular profiling of cancer: the future of personalized cancer medicine—a primer on cancer biology and the tools necessary to bring molecular testing to the clinic. Semin Oncol 38:173–185PubMedCrossRefGoogle Scholar
  41. 41.
    Bui L, Rempel E, Reeson D et al (2006) Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol 93:439–445PubMedCrossRefGoogle Scholar
  42. 42.
    Kotake K, Honjo S, Sugihara K et al (2011) Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol 42:29–35PubMedCrossRefGoogle Scholar
  43. 43.
    Lemmens VE, van Lijnschoten I, Janssen-Heijnen ML et al (2006) Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study. Ann Oncol 17:1803–1809PubMedCrossRefGoogle Scholar
  44. 44.
    Piso P, Dahlke MH, Mirena P et al (2004) Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients. J Surg Oncol 86:115–121PubMedCrossRefGoogle Scholar
  45. 45.
    Shen SS, Haupt BX, Ro JY et al (2009) Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med 133:781–786PubMedGoogle Scholar
  46. 46.
    Rullier A, Laurent C, Capdepont M et al (2008) Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 32:45–50PubMedCrossRefGoogle Scholar
  47. 47.
    Akasu T, Takawa M, Yamamoto S et al (2008) Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence. Ann Surg Oncol 15:2668–2676PubMedCrossRefGoogle Scholar
  48. 48.
    Gunderson LL, Jessup JM, Sargent DJ et al (2009) Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol 28:256–263PubMedCrossRefGoogle Scholar
  49. 49.
    Meguid RA, Slidell MB, Wolfgang CL et al (2008) Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 15:2388–2394PubMedCrossRefGoogle Scholar
  50. 50.
    Wang H, Wei XZ, Fu CG et al (2010) Patterns of lymph node metastasis are different in colon and rectal carcinomas. World J Gastroenterol 16:5375–5379PubMedCrossRefGoogle Scholar
  51. 51.
    Evans MD, Robinson S, Badiani S et al (2011) Same surgeon: different centre equals differing lymph node harvest following colorectal cancer resection. Int J Surg Oncol 2011:406517PubMedGoogle Scholar
  52. 52.
    Rosenberg R, Engel J, Bruns C et al (2010) The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251:1070–1078PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2012

Authors and Affiliations

  1. 1.Institute for Clinical Outcomes Research and Education (iCORE)Dublin 4Ireland

Personalised recommendations